Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study.

ABSTRACT:

Background

There is a disparity in the economic return achievable for antimicrobials compared with other drugs because of the need for stewardship. This has led to a decline in pharmaceutical companies' willingness to invest in the development of these drugs and a consequent global interest in funding models where reimbursement is de-linked from sales.

Objectives

To explore the perspective of stakeholders regarding the feasibility of de-linked reimbursement of antimicrobials in Australia.

Methods

Semi-structured interviews were conducted with 18 participants sourced from the pharmaceutical industry and individuals representing public-sector payers or regulators. Interviews were transcribed verbatim, coded and thematically analysed using the framework method.

Result

SUBMITTER: Hillock NT 

PROVIDER: S-EPMC8210305 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature